首页> 外文期刊>Synlett >Concise Synthesis of (2S,3R)-3-Hydroxy-2-phenylpiperidine: An AdvancedKey Intermediate of Human Non-Peptide NK-1 Receptor Antagonists
【24h】

Concise Synthesis of (2S,3R)-3-Hydroxy-2-phenylpiperidine: An AdvancedKey Intermediate of Human Non-Peptide NK-1 Receptor Antagonists

机译:简明合成(2S,3R)-3-羟基-2-苯基哌啶:人类非肽NK-1受体拮抗剂的高级关键中间体。

获取原文
获取原文并翻译 | 示例
           

摘要

The rapid, high-yielding synthesis of (2S,3R)-3-hy-droxy-2-phenylpiperidine, a known advanced key intermediate ofsome non-peptide human NK-1 receptor antagonists such as (+)-CP-99,994, (+)-CP-122,721 and (+)-LP-733,060, is reported. Thissynthesis involves the stereoselective addition of racemic 3-(meth-oxymethoxy)allenylzinc bromide to enantiopure (Rs,E)-N-2-ben-zylidene-2-methylpropane-2-sulfinamide and a ring-closingmetathesis reaction as the key steps. Following this procedure,(2S,3R)-3-hydroxy-2-phenylpiperidine is obtained in seven steps in56.2% overall yield.
机译:(2S,3R)-3-hy-droxy-2-phenylpiperidine(2S,3R)-3-hy-droxy-2-phenylpiperidine的快速,高产率合成,这是一些非肽类人NK-1受体拮抗剂(如(+)-CP-99,994,(报告了+)-CP-122,721和(+)-LP-733,060。该合成涉及将外消旋3-(甲基-氧甲氧基)烯基溴化锌立体选择性地加成对映体(Rs,E)-N-2-苯-亚苄基-2-甲基丙烷-2-亚磺酰胺,并将开环复分解反应作为关键步骤。按照该程序,通过7个步骤获得(2S,3R)-3-羟基-2-苯基哌啶,总产率为56.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号